The Click-iT RNA Imaging Kit (Invitrogen) was used according to the manufacturer's specifications to assess de novo RNA synthesis in situ. Briefly, GFP/GFP-MeVM expressing COS-7 cells (23 h p.t.) or MeV infected Vero/hSLAM cells (11 h post infection) were treated with 1 mM EU (5-ethynyluridine) for 1 h, fixed with 4% formaldehyde, permeabilised with 0.5% Triton X-100, and stained for de novo synthesized RNA using Alexa 594-azide. Cells were then imaged by CLSM. Control cells were treated with actinomycin D (5 μg/ml) for 1 h prior to EU treatment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.